Report
Rob Hales
EUR 850.00 For Business Accounts Only

Morningstar | Solvay Company Report

Belgium-based Solvay has largely completed its transformation to a specialty chemicals company, although there are still some commodity chemicals where the company has a leading market position, notably soda ash and peroxides. However, we still don't see a moat, given that high capital intensity continues to weigh on ROIC, leaving us with limited confidence in the company's ability to generate sustained returns above the cost of capital. A EUR 150 million cost-cutting plan was announced in 2018 to adjust the company's cost base to its new, leaner business portfolio. Successful execution of said program, with some evidence that current high margins have staying power in an economic slowdown, would go far in building our confidence around a potential moat for Solvay. Solvay's sales are broadly diversified geographically and by end markets, although automotive and aerospace tend to take centre stage. In addition, oil and gas is often topical, given Solvay's exposure to the highly cyclical U.S shale market. Sales are split fairly evenly between Europe, North America, and Asia. The company's business is segmented into advanced materials (50% of EBIT), advanced formulations (20% of EBIT), and performance chemicals (30% of EBIT). Advanced materials is the most attractive segment, given that it houses the moatworthy and high-growth specialty polymers and composite materials businesses. Advanced formulations is another growth driver for the company, particularly the Novecare surfactants business, but is subject to the whims of the oil and gas market, given that many of Novecare's high-margin solutions are used for stimulation in oil and gas wells. Performance chemicals is the legacy commodity chemical business, but this is by no means a weak link. Solvay is a leading global player in soda ash and peroxides, which generate significant cash for the company. On the other hand, we think the remaining business lines, Coatis and functional polymers, are noncore and will likely be divested over time.
Underlying
Solvay SA

Solvay is engaged in chemical and plastic businesses worldwide. Co. offers chemical products such as advanced materials, barium strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as Spire ultra polymers, Solviva biomaterials, and sulfone polymers. Co. structures its activities around five operating segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers and Corporate & Business Services, each with its own specific business model and each comprised of Global Business Units (GBUs).

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Rob Hales

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch